DalsnaFinance Account

MiniMed Group $MMED

Health Care

Russell 2000 California

Create a scorecard

$17.49

-0.30 (-1.69%)

As of Oct 20, 2026, 6:42 PM EDT · cached

Price history

Loading chart…

Today's analyst average Analyst average over timeIndividual analyst targets Analyst history starts Oct 12, 2026, the first target we tracked for MMED.

MiniMed Group (MMED) is trading down at $17.49 (-1.69%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.

IPO: March 6, 2026 · $20.00 offering · NASDAQ · View IPO details →

Analyst price targets on MMED

One firm's current price target on MiniMed Group: $22 — 26% above the current $17.5. Each is tracked to its date and scored the same way a member's call is.

Jefferies $19.7 → $22 by Oct 2027 Hold Oct 12, 2026 via Investing.com · Jefferies's track record

Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.

MiniMed Group revenue & net income history (FY2024–FY2026)

RevenueNet incomeNet margin (right axis, %)

MiniMed Group annual financial statements
	FY2024Apr 2024	FY2025Apr 2025	FY2026Apr 2026
Income statement
Revenue	$2.47B	$2.71B	$3.10B
Growth (year over year)	—	+10.0%	+14.3%
Gross profit	$1.44B	$1.53B	$1.68B
Gross margin	58.2%	56.3%	54.2%
Operating income	−$69.0M	−$146.0M	−$190.0M
Operating margin	−2.8%	−5.4%	−6.1%
Net income	−$112.0M	−$213.0M	−$333.0M
Net margin	−4.5%	−7.8%	−10.7%
EPS (diluted)	−$0.44	−$0.84	−$1.30
Balance sheet
Cash and equivalents	$54.0M	$11.0M	$298.0M
Total assets	—	$4.20B	$4.63B
Total liabilities	—	$871.0M	$1.02B
Shareholders' equity	$3.45B	$3.33B	$3.61B
Cash flow
Operating cash flow	$41.0M	$140.0M	−$197.0M
Capital expenditure	$148.0M	$193.0M	$223.0M
Free cash flow	−$107.0M	−$53.0M	−$420.0M

RevenueNet incomeNet margin (right axis, %)

MiniMed Group quarterly financial statements
	Q2 FY25Oct 2024	Q3 FY25Jan 2025	Q4 FY25^†Apr 2025	Q1 FY26Jul 2025	Q2 FY26Oct 2025	Q3 FY26Jan 2026	Q4 FY26^†Apr 2026	Q1 FY27Jul 2026
Income statement
Revenue	—	$687.0M	$724.0M	$723.0M	—	$790.0M	$837.0M	$843.0M
Growth (year over year)	—	—	—	—	—	+15.0%	+15.6%	+16.6%
Gross profit	—	$395.0M	$405.0M	$409.0M	—	$362.0M	$480.0M	$465.0M
Gross margin	—	57.5%	55.9%	56.6%	—	45.8%	57.3%	55.2%
Operating income	—	$21.0M	−$148.0M	−$13.0M	—	−$100.0M	−$93.0M	$5.00M
Operating margin	—	3.1%	−20.4%	−1.8%	—	−12.7%	−11.1%	0.6%
Net income	−$5.00M	−$10.0M	−$179.0M	−$19.0M	−$5.00M	−$119.0M	−$190.0M	$0
Net margin	—	−1.5%	−24.7%	−2.6%	—	−15.1%	−22.7%	0.0%
EPS (diluted)	—	−$0.04	−$0.68	−$0.08	—	−$0.47	−$0.71	$0.00
Balance sheet
Cash and equivalents	—	$10.0M	$11.0M	$9.00M	—	$10.0M	$298.0M	$207.0M
Total assets	—	—	$4.20B	—	—	$4.34B	$4.63B	$4.72B
Total liabilities	—	—	$871.0M	—	—	$881.0M	$1.02B	$1.10B
Shareholders' equity	$3.46B	$3.48B	$3.33B	$3.54B	$3.56B	$3.46B	$3.61B	$3.62B
Cash flow
Operating cash flow	—	—	$83.0M	−$141.0M	—	—	−$170.0M	−$49.0M
Capital expenditure	—	—	$57.0M	$53.0M	—	—	$56.0M	$41.0M
Free cash flow	—	—	$26.0M	−$194.0M	—	—	−$226.0M	−$90.0M

From MiniMed Group's 10-K and 10-Q filings with the SEC; its fiscal year ends in April. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →